Genomic Variant Impact Assessment & Interpretation
Assess functional impact and clinical significance of genomic variants
What You Can Do
You can analyze annotated variants from VCF files and prediction tools (VEP, SnpEff, InterVar) to assess pathogenicity, predict functional consequences, and cross-reference multiple annotation sources including ACMG guidelines, CADD scores, and splicing predictions. Claude helps you generate reproducible variant interpretation reports that bridge computational outputs with biological and clinical significance for disease studies, pharmacogenomics, and regulatory submissions.
Features
rank variants by predicted impact (loss-of-function, missense, regulatory) using SIFT, PolyPhen-2, and conservation metrics
cross-reference ACMG pathogenicity criteria, ClinVar, gnomAD population frequencies, and disease-specific databases in a unified framework
assess splicing effects (SpliceAI), protein folding (AlphaFold), and domain disruption for novel variants
connect variants to published evidence linking genotype to phenotype for genes in your panel
generate structured reports with criteria, evidence trails, and confidence assessments for wet lab collaboration and publication
evaluate drug-metabolizer phenotypes and variant-drug interaction significance
build and apply custom criteria for targeted gene panels, cancer hotspots, or monogenic disease genes
Example Output
Example 1: Missense Variant in TP53
- Variant: chr17:7577121 C>T (p.R248Q)
- Predicted Impact: Loss of function (missense in DNA-binding domain)
- ACMG Classification: Likely Pathogenic (PVS1, PS1, PM2_supporting)
- Evidence: Known hotspot in IARC TP53 database; 47 ClinVar submissions as pathogenic; gnomAD frequency <0.0001
- Functional Prediction: PolyPhen-2 = 0.95 (probably damaging); SIFT score = deleterious
- Recommendation: HIGH PRIORITY — strong evidence for functional disruption in cancer context
Example 2: Synonymous Variant in BRCA1 Exon 5
- Variant: chr17:41196312 G>A (p.Asp222=)
- Predicted Impact: Potential splicing disruption
- SpliceAI Score: 0.82 (high confidence for exon skipping)
- Functional Prediction: MaxEntScan indicates 65% reduction in splice site strength
- gnomAD Frequency: 0.0008 (present in population)
- Recommendation: MODERATE PRIORITY — investigate RNA-level consequences; consider functional validation
Example 3: Intergenic Variant Near PTEN Promoter
- Variant: chr10:89654321 A>G
- Predicted Impact: Potential regulatory disruption
- Conservation: phyloP score = 4.2 (moderately conserved across mammals)
- TF Binding Prediction: TRANSFAC indicates altered TP53 binding site
- ClinVar: No submissions; gnomAD frequency = 0.001
- Recommendation: LOW-MODERATE PRIORITY — functional validation recommended before clinical classification
What's Included
- SKILL.md: Core instruction file for variant interpretation workflow and ACMG criteria integration
- Variant Interpretation Template: Structured markdown template for documenting variant assessment with evidence fields
- ACMG Pathogenicity Checklist: Interactive checklist for applying American College of Medical Genetics criteria (PVS, PS, PM, BP, BS categories)
- Annotation Source Reference Guide: Quick-reference table mapping prediction tools (CADD, SpliceAI, PolyPhen-2, SIFT, AlphaFold) to interpretive thresholds
- Literature Integration Workflow: Framework for cross-referencing ClinVar, IARC, dbSNP, and PubMed to support pathogenicity calls
Who It's For
- Bioinformatics scientists — systematize variant interpretation pipelines and standardize reporting across projects
- Computational biologists — prioritize variants for functional validation and reduce time spent on literature manual review
- Clinical geneticists — document evidence trails for rare disease diagnoses and regulatory submissions
- Pharmacogenomics specialists — assess drug-metabolizer phenotypes and predict variant-drug interactions
- Research scientists in oncology — interpret cancer-associated variants and identify driver mutations in tumor panels
Best For
- Variant prioritization from whole-exome or whole-genome sequencing studies
- Pathogenicity assessment for novel variants in monogenic disease genes
- Pharmacogenomics interpretation and drug-metabolizer phenotyping
- Cancer variant annotation and driver mutation identification
- Preparation of variant interpretation reports for publication, patents, or regulatory submissions
You might also like
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-wThis skill interprets your FEA simulation results and extracts actionable design improvements. You can pinpoint stress concentrations, validate designs against safety factors and material limits, and receive specific geometry recommendations to reduce weight or improve performance. By automating FEA post-processing, you compress design iteration cycles and make engineering decisions faster.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
You can analyze equipment sensors, operational logs, and historical maintenance data to predict failures weeks in advance. Claude generates actionable maintenance schedules, identifies high-risk assets, and calculates the financial impact of preventive vs. reactive maintenance. This skill transforms raw operational data into strategic maintenance decisions that minimize downtime and extend asset life.
by kody-w